Q&A: How do we report alemtuzumab?
APCs Insider, August 14, 2015
Want to receive articles like this one in your inbox? Subscribe to APCs Insider!
Q: Our physicians want to administer a drug that’s new to us called alemtuzumab, with the brand name Lemtrada®. However, we found no information concerning a HCPCS code for reporting this drug. How can we bill Medicare?
A: Alemtuzumab is approved by the FDA for the treatment of relapsing forms of multiple sclerosis. CMS created a new HCPCS level II code for reporting this biological. Q9979 (injection, alemtuzumab, 1 mg) will be a valid HCPCS code for Medicare effective October 1.
Providers will want to be sure that their charge structures are set up to report the appropriate number of units to reflect the amount of the drug administered based on the "per 1 mg" description.
In addition, if alemtuzumab is provided in a single use vial, providers must document in the patient’s medical record any amount of drug that is wasted to support the additional units reported on the claim.
For more information, see Transmittal 3304.
Editor’s note: Denise Williams, RN, CPC-H, seniorvice president of revenue integrity services at Health Revenue Assurance Associates, Inc., in Fort Lauderdale, Florida, answered this question.
Want to receive articles like this one in your inbox? Subscribe to APCs Insider!
Related Products
-
Briefings on APCs
Worried about the complexities of the new rules under OPPS and APCs? Briefings on APCs helps you understand the new rules...
-
HIM Briefings
Guiding Health Information Management professionals through the continuously changing field of medical records and toward a...
-
Briefings on Coding Compliance Strategies
Submitting improper Medicare documentation can lead to denial of fees, payback, fines, and increased diligence from payers...
-
Briefings on HIPAA
How can you minimize the impact of HIPAA? Subscribe to Briefings on HIPAA, your health information management resource for...
-
APCs Insider
This HTML-based e-mail newsletter provides weekly tips and advice on the new ambulatory payment classifications regulations...
Most Popular
- Articles
-
- Don't forget the three checks in medication administration
- Practice the six rights of medication administration
- Follow 72-hour and 24-hour rules
- Note similarities and differences between HCPCS, CPT® codes
- Complications from immobility by body system
- OSHA fines hospitals for PPE failures related to COVID-19
- Q&A: Primary, principal, and secondary diagnoses
- Skills of effective case managers
- OB services: Coding inside and outside of the package
- Know guidelines and subtle differences in code descriptions for laceration repairs
- E-mailed
-
- OSHA fines hospitals for PPE failures related to COVID-19
- Tip: Know the common bunionectomy procedure codes and how to use them
- Simplify Documentation of Missed Visits
- Residency coordinator salaries
- Q&A: CHF vs. cor pulmonale
- Infant abduction drills could have your code pink team seeing red
- Guidelines for stem cell storage and collection
- Follow 72-hour and 24-hour rules
- Cornerstone for CDI success is clear goals, objectives
- CMS replaces clinic E/M visit levels with single G-code
- Searched
